Park West Asset Management LLC Cel Sci Corp Transaction History

Park West Asset Management LLC

  • $1.24 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$7.54 - $17.05 $452,400 - $1.02 Million
-60,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$6.0 - $9.6 $360,000 - $576,000
60,000 New
60,000 $536,000

Others Institutions Holding CVM

# of Institutions
71
Shares Held
6M
Call Options Held
27.1K
Put Options Held
150K
View Full List

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $30.4M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Park West Asset Management LLC Portfolio

Follow Park West Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park West Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email